Home > Insider Trading > Filing (0001566028-13-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887497	Hi Tech Pharmacal Co Inc	HITK	Pharmaceutical Preparations (2834)	112638720

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263136	J William Peters	C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701	Vp And Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-01-24	6,250	$10.68	6,250	No	4	M	Direct
Common Stock	Acquisiton	2013-01-24	1,611	$10.68	7,861	No	4	M	Direct
Common Stock	Disposition	2013-01-24	7,861	$38.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-01-24	6,250	$0.00	6,250	$10.68
Common Stock	Stock Option (Right to Buy)	Disposition	2013-01-24	1,611	$0.00	1,611	$10.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-02-02	2017-02-02	No	4	M	Direct
17,139	2009-01-29	2018-01-29	No	4	M	Direct

Footnotes

The option exercises and open market sale were made pursuant to a 10b5-1 trading plan adopted by the filer in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.003 to 38.02, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
Other than the option to acquire 17,139 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 146,250 shares of Hi-Tech Common Stock (for aggregate options to acquire a total of 163,389 shares of Common Stock), which options were granted on various dates, with varying exercise prices and exercisable and expiration dates.